Preferred Label : methylphenidate;

Details


Main resources

You can consult :


https://www.assurance-maladie.ameli.fr/etudes-et-donnees/2024-age-relatif-methylphenidate-orthophonie-enfants
2024
France
technical report
technical report
Child
Child
france
france
age, nos
age, nos
Methylphenidate Measurement
Methylphenidate Measurement
methylphenidate
methylphenidate
Offspring
Offspring
Speech Pathology
Speech Pathology
Outcome of Therapy
Outcome of Therapy
Treatment Factor
Treatment Factor
french
french
Autonomic Nervous System
Autonomic Nervous System
CHFR Gene
CHFR Gene
speech therapy
speech therapy
child, nos
child, nos
GDC Treatment Effect Terminology
GDC Treatment Effect Terminology
child
child
methylphenidate
methylphenidate
Elderly
Elderly
Therapeutic Effect
Therapeutic Effect
Transcription Initiation
Transcription Initiation
Per Hundred Thousand
Per Hundred Thousand
Initiation
Initiation
Advanced Glycation End Product
Advanced Glycation End Product
Methylphenidate
Methylphenidate
Subject Age
Subject Age
speech therapy, nos
speech therapy, nos
Relative Value
Relative Value

---
https://www.has-sante.fr/jcms/p_3305318/fr/ritaline-lp-methylphenidate-tdah
2021
false
false
false
France
evaluation of the transparency committee
methylphenidate
indicators
lipoprotein(a)
indicators and reagents
attention deficit disorder with hyperactivity
traction
methylphenidate
Ritalin
indication of

---
Nous contacter.
06/09/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.